Cargando…
Correction: Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
Autores principales: | Schwarze, Lea Isabell, Głów, Dawid, Sonntag, Tanja, Uhde, Almut, Fehse, Boris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935381/ https://www.ncbi.nlm.nih.gov/pubmed/36418432 http://dx.doi.org/10.1038/s41434-022-00373-y |
Ejemplares similares
-
Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
por: Schwarze, Lea Isabell, et al.
Publicado: (2021) -
Automated production of CCR5-negative CD4(+)-T cells in a GMP-compatible, clinical scale for treatment of HIV-positive patients
por: Schwarze, Lea Isabell, et al.
Publicado: (2021) -
CRISPR-to-Kill (C2K)–Employing the Bacterial Immune System to Kill Cancer Cells
por: Głów, Dawid, et al.
Publicado: (2021) -
Deep Characterization and Comparison of Different Retrovirus-like Particles Preloaded with CRISPR/Cas9 RNPs
por: Wichmann, Max, et al.
Publicado: (2023) -
How to package and SEND mRNA: a novel “humanized” vector system based on endogenous retroviruses
por: Riecken, Kristoffer, et al.
Publicado: (2021)